Jagsonpal Pharmaceuticals Boosts Portfolio With Strategic Yash Pharma Acquisition
Jagsonpal acquires Yash Pharma, expanding into dermatology and pediatrics, enhancing market position.
Breaking News
Jun 28, 2024
Mrudula Kulkarni
Jagsonpal Pharmaceuticals has announced the acquisition of
Yash Pharma's businesses in India and Bhutan, facilitated by boutique
investment banking firm Growthally Advisors. This strategic move not only
expands Jagsonpal's therapeutic footprint but also strengthens its market
position significantly.
The merger is particularly noteworthy as it brings together
two companies with complementary strengths. With a 60-year legacy focused on
gynaecology and orthopaedics, Jagsonpal Pharmaceuticals now integrates Yash
Pharma's extensive portfolio of 33 dermatology and paediatrics brands. This
expansion not only diversifies Jagsonpal's product range but also marks its
entry into a new market segment valued at Rs 20,000 crore (Source: IQVIA),
promising substantial growth prospects.
Investor presentation of Jagsonpal stated, “This acquisition
is the perfect recipe for Jagsonpal. Yash Pharma’s strengths in dermatology and
pediatrics can now be leveraged to align with our long-term growth objectives.
Now, with our portfolio getting extended with this access to new customer
segments, the company is poised to significantly strengthen our market
position.”
Growthally Advisors Pvt. Ltd., a specialized boutique
investment banking firm well-versed in the nuances of the Indian Pharmaceutical
and Healthcare sectors, successfully guided this intricate transaction.
Leveraging their deep expertise in mergers and acquisitions, they seamlessly
aligned their vision of fostering sustainable and profitable long-term growth
with Jagsonpal’s strategic objectives.
“We are proud to have been facilitators of this mutually
rewarding partnership. We have always been helping emerging corporates in an
Indian Pharmaceuticals and healthcare industry in unlocking their long-term
objectives through innovative solutions that optimise their growth trajectory.
We believe that this transaction is a perfect example of how strategic
acquisitions can ensure benefits for all stakeholders”, stated Bhupinder Garg,
Managing Director of Growthally Advisors.